NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Tempo Bioscience, Inc.

Tempo Bioscience, Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://tempobioscience.com

Last Round

Grant

Mar 10, 2025

Total Funding Raised

$17.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Tempo Bioscience, Inc. is a biotechnology company that develops human induced pluripotent stem cell (iPSC)-based models and proprietary biosensor technologies for drug discovery, preclinical development, and diagnostic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

induced pluripotent stem cellsiPSCbiosensor assayspreclinical drug discoverytoxicology testinganimal-free testingin vitro modelslive-cell imagingdisease modelingdrug efficacyregenerative medicinecustom cell engineeringorgan-on-a-chipalternative methods3Rs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tempo Bioscience, Inc. Comparables

Compare Tempo Bioscience, Inc. with similar companies based on industry and business-model similarity.

Tempo Bioscience, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iXCells Biotechnologies
84%
Axol Bioscience
84%
Greenstone Biosciences
83%

Tempo Bioscience, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 10, 2025
Series AMar 19, 2024
VC RoundSep 25, 2020

Tempo Bioscience, Inc. Investors

Notable investors and investment history

Tempo Bioscience, Inc. investors
InvestorRounds
NIH RADxGrant
AJAX Capital PartnersSeries A
Johnson & Johnson Innovation – JJDCSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 48% MoM, reaching 7.7K.

Tempo Bioscience, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tempo Bioscience, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tempo Bioscience, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range3
Year Founded2013
Last FundingMar 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.